SCHEMBL26616558

SCHEMBL26616558

N#Cc1nc(CCCc2ccccc2)oc1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
LMNA P02545 5/20 0.48
TSHR P16473 4/20 0.48
HTT P42858 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
PKM P14618 1/20 0.48
HPGD P15428 5/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
GAA P10253 4/20 0.44
MAPT P10636 9/20 0.40
TDP1 Q9NUW8 3/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 3/20 0.38
GLA P06280 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26616385 0.82 LMNA (0.48) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL26616517 0.76 HTT (0.75) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL28280910 0.67 RAB9A (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL26616575 0.66 DAO (0.50) ALDH1A1NPC1RAB9APKMMEN1
SCHEMBL28777981 0.65 FAAH (0.46) FAAH
SCHEMBL54347 0.64 HTR2A (0.70) ALDH1A1SMN1; SMN2HPGDTDP1MAPK1
SCHEMBL30583226 0.64 NPC1 (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
Ammonia Solution, Strong SCHEMBL8817973 0.62 HTR2A (0.67) ALDH1A1SMN1; SMN2HPGDTDP1MAPK1
SCHEMBL9069707 0.62 HTR2A (0.75) ALDH1A1SMN1; SMN2HPGDMAPK1HSD17B10
SCHEMBL29268834 0.62 HTR2A (0.67) ALDH1A1SMN1; SMN2HPGDTDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288559-A1 PREP BINDING LIGANDS POLKU THERAPEUTICS OY (FI) 2025-09-18 US disclosed
EP-4514781-A1 PREP BINDING LIGANDS Polku Therapeutics OY (FI) 2025-03-05 EP disclosed
CN-119451944-A PREP binding ligands 珀尔库治疗有限公司 2025-02-14 CN disclosed
WO-2023209191-A1 PREP BINDING LIGANDS UNIVERSITY OF HELSINKI (FI) 2023-11-02 WO disclosed
WO-2023209191-A1 PREP BINDING LIGANDS UNIVERSITY OF HELSINKI (FI) 2023-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250288559-A1 PREP BINDING LIGANDS PREP, ERAP2, CTSA ALDH1A1 4707/4885LMNA 1543/4885TSHR 3591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.